Association between mitochondrial DNA content and opium exposure.
Elmira Ebrahimi1,2, Mohammad H Akhavan1,3, Rahim Akrami4,5
1Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Journal of Biochemical and Molecular Toxicology
|October 9, 2020
Summary
Mitochondrial DNA (mtDNA) copy number is significantly higher in opium users and dual users, suggesting it may serve as a biomarker for opium exposure and its potential health impacts.
Area of Science:
- Biomarkers
- Toxicology
- Genetics
Background:
- Mitochondrial DNA (mtDNA) copy number is increasingly recognized for its role in various diseases.
- Limited research exists on mtDNA copy number as a biomarker for substance exposure, particularly opium.
Purpose of the Study:
- To investigate the association between opium exposure and mtDNA copy number.
- To determine if mtDNA copy number can serve as a potential biomarker for opium use.
Main Methods:
- A cross-sectional study involving 205 participants (opium users, cigarette users, dual users, never users).
- Quantitative real-time PCR was used to measure mtDNA copy number in blood samples.
- Statistical analysis adjusted for confounding factors like age and sex.
Main Results:
- Opium-only users and dual users showed significantly higher mtDNA copy number compared to never users.
- Cigarette smoking showed a non-significant indirect association with mtDNA content.
- The observed increase in mtDNA may be a compensatory response to oxidative damage from opium.
Conclusions:
- mtDNA copy number may be altered by opium exposure, indicating its potential as a biomarker.
- Further research is needed to explore the link between mtDNA changes, opium's carcinogenicity, and early detection strategies.
Related Concept Videos
02:59Animal Mitochondrial Genetics
8.7K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.7K
01:25Analgesia and Pain Management
1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
646
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
646
01:22Opioid Receptors: Overview
3.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.4K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
743
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
743